SOLARA ACTIVE PHARMA SCIENCES
Quarterly Results Analysis [Dec2024]
SOLARA ACTIVE PHARMA SCIENCES Quarterly Results
Consolidated | Dec2024 UnAudited |
Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹300 Cr | ₹347 Cr | ₹363 Cr | ₹299 Cr | ₹212 Cr | ₹425 Cr | ₹352 Cr | ₹381 Cr |
Expenses | ₹243 Cr | ₹286 Cr | ₹322 Cr | ₹290 Cr | ₹374 Cr | ₹388 Cr | ₹333 Cr | ₹332 Cr |
Operating Income | ₹58 Cr | ₹61 Cr | ₹42 Cr | ₹10 Cr | ₹-162 Cr | ₹38 Cr | ₹19 Cr | ₹49 Cr |
Other Income | ₹1 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹0 Cr | ₹1 Cr | ₹2 Cr | ₹5 Cr |
Interest | ₹27 Cr | ₹28 Cr | ₹31 Cr | ₹31 Cr | ₹25 Cr | ₹24 Cr | ₹25 Cr | ₹22 Cr |
Depreciation | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹25 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr | ₹26 Cr |
Profit Before Tax | ₹8 Cr | ₹8 Cr | ₹-13 Cr | ₹-167 Cr | ₹-275 Cr | ₹-17 Cr | ₹-29 Cr | ₹5 Cr |
Profit After Tax | ₹8 Cr | ₹8 Cr | ₹-13 Cr | ₹-255 Cr | ₹-275 Cr | ₹-17 Cr | ₹-19 Cr | ₹4 Cr |
EPS | ₹2.01 | ₹1.99 | ₹-3.35 | ₹-65.37 | ₹-76.48 | ₹-4.39 | ₹-5.01 | ₹0.96 |
Industry Peers & Returns | 1W | 1M | 1Y |
SOLARA ACTIVE PHARMA SCIENCES | 8.7% | 6% | 6.1% |
SUN PHARMACEUTICAL INDUSTRIES | -7.3% | 1.1% | 15.2% |
DIVIS LABORATORIES | -3.5% | 12.9% | 53.4% |
CIPLA | 0.1% | 9.2% | 6.5% |
TORRENT PHARMACEUTICALS | -1% | 0.2% | 19.9% |
DR REDDYS LABORATORIES | 3.1% | 9.8% | -7.6% |
MANKIND PHARMA | 5.5% | 5% | 8.8% |
ZYDUS LIFESCIENCES | 0.5% | 5.6% | -10.5% |
LUPIN | -0.4% | 6.1% | 26.5% |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | -13.44 % |
Y-o-Y | 41.70 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Dec2024 | ₹300 Cr | -13.44 | |
Sep2024 | ₹347 Cr | -4.55 | |
Jun2024 | ₹363 Cr | 21.39 | |
Mar2024 | ₹299 Cr | 41.28 | |
Dec2023 | ₹212 Cr | -50.16 | |
Sep2023 | ₹425 Cr | 20.70 | |
Jun2023 | ₹352 Cr | -7.44 | |
Mar2023 | ₹381 Cr | - |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | -5.92 % |
Y-o-Y | Positive |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Dec2024 | ₹58 Cr | -5.92 | |
Sep2024 | ₹61 Cr | 46.25 | |
Jun2024 | ₹42 Cr | 329.51 | |
Mar2024 | ₹10 Cr | Positive | |
Dec2023 | ₹-162 Cr | Negative | |
Sep2023 | ₹38 Cr | 96.81 | |
Jun2023 | ₹19 Cr | -60.79 | |
Mar2023 | ₹49 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 8.72 % |
Y-o-Y | Positive |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Dec2024 | 19.21% | 8.72 | |
Sep2024 | 17.67% | 53.25 | |
Jun2024 | 11.53% | 253.68 | |
Mar2024 | 3.26% | Positive | |
Dec2023 | -76.29% | Negative | |
Sep2023 | 8.85% | 62.98 | |
Jun2023 | 5.43% | -57.61 | |
Mar2023 | 12.81% | - |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 1.00 % |
Y-o-Y | Positive |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Dec2024 | ₹8 Cr | 1.00 | |
Sep2024 | ₹8 Cr | Positive | |
Jun2024 | ₹-13 Cr | Negative | |
Mar2024 | ₹-255 Cr | Negative | |
Dec2023 | ₹-275 Cr | Negative | |
Sep2023 | ₹-17 Cr | Negative | |
Jun2023 | ₹-19 Cr | Negative | |
Mar2023 | ₹4 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 16.45 % |
Y-o-Y | Positive |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Dec2024 | 2.69 % | 16.45 | |
Sep2024 | 2.31 % | Positive | |
Jun2024 | -3.7 % | Negative | |
Mar2024 | -85.31 % | Negative | |
Dec2023 | -129.91 % | Negative | |
Sep2023 | -4.01 % | Negative | |
Jun2023 | -5.42 % | Negative | |
Mar2023 | 0.99 % | - |
SOLARA ACTIVE PHARMA SCIENCES Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 1.01 % |
Y-o-Y | Positive |
Quarters | EPS | % Change | |
---|---|---|---|
Dec2024 | ₹2.01 | 1.01 | |
Sep2024 | ₹1.99 | Positive | |
Jun2024 | ₹-3.35 | Negative | |
Mar2024 | ₹-65.37 | Negative | |
Dec2023 | ₹-76.48 | Negative | |
Sep2023 | ₹-4.39 | Negative | |
Jun2023 | ₹-5.01 | Negative | |
Mar2023 | ₹0.96 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs CIPLA LTD
TORRENT PHARMACEUTICALS LTD vs DR REDDYS LABORATORIES LTD vs MANKIND PHARMA LTD